Literature DB >> 7050161

In vitro lymphocyte proliferation in response to type III group B streptococci.

M A Lillie, C S Cody, S D Douglas, R A Polin.   

Abstract

The in vitro cell-mediated responses to group B streptococci (GBS) and the relationship of cell-mediated immunity to specific humoral immunity to type III GBS were investigated. Blood was obtained from 20 adult volunteers, and lymphocytes were isolated and cultured in microtiter plates. Each well contained 2 x 10(5) lymphocytes, 15% autologous serum, and either GBS (cell-to-organism ratio of 1:10, 1:1, or 1:0.1), phytohemagglutinin, streptokinase-streptodornase, or RPMI 1640. Cells were harvested at 5, 6, or 7 days, and DNA synthesis was quantitated. Serum antibody titers were determined with an enzyme-linked immunosorbent assay. Maximal lymphocyte responses occurred at 6 days of culture and at a cell-to-organism ratio of 1:1. Individuals with significant antibody titers to type III GBS, as well as those with undetectable antibody, responded to GBS (stimulation index greater than 10). There was a significant difference (P less than 0.001) between mean antibody concentrations in responders (stimulation index greater than 10) and nonresponders (stimulation index less than 10). Thus, the in vitro responses to GBS may be both to a specific antigen and to a nonspecific mitogen and may be important in host immunity to GBS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050161      PMCID: PMC272305          DOI: 10.1128/jcm.16.1.111-114.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Many bacterial species are mitogenic for human blood B lymphocytes.

Authors:  G Banck; A Forsgren
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

2.  Neonatal cellular and humoral immunity to group B streptococci.

Authors:  H R Hill; A O Shigeoka; R T Hall; V G Hemming
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

3.  Cellular and antibody reactions to streptococcal M protein types 1, 3, 6 and 12.

Authors:  L M Pachman; E N Fox
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

4.  Evidence for a soluble lymphocyte factor in the transplacental transmission of T-lymphocyte responses to Mycobacterium leprae.

Authors:  R S Barnetson; G Bjune; M E Duncan
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

5.  Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; P Chase; S H Polmar
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

6.  Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

8.  Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide.

Authors:  O Ringdén; B Rynnel-Dagöö; E M Waterfield; E Möller; G Möller
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Polyclonal activation of immunoglobulin secretion in B lymphocytes induced by staphylococcal peptidoglycan.

Authors:  R Dziarski
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

10.  Immunodeterminant specificity of human immunity to type III group B streptococcus.

Authors:  D L Kasper; C J Baker; R S Baltimore; J H Crabb; G Schiffman; H J Jennings
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.